Genomic Convergence: Emerging Pathways, Mechanisms, and Druggable Targets in Precision Medicine for COVID Long-haul Research

Author: John Murphy, CEO COVID-19 Long-haul Foundation Abstract The past three years have witnessed an unprecedented acceleration in genomic discovery, driven by advances in single-cell sequencing, spatial transcriptomics, and integrative…[...]

Read More

Diagnostic Biomarkers and Imaging Modalities in Long COVID: Toward Precision Detection and Monitoring

Author: John Murphy, President, COVID-19 Long-haul Foundation Abstract Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), presents with a complex array of symptoms affecting multiple organ systems. Accurate diagnosis…[...]

Read More

Systemic Reluctance: Medical Inertia and the Pharmaceutical Industry’s Influence on Long COVID Treatment

Abstract Despite the global burden of Long COVID, the medical profession has demonstrated a striking reluctance to engage in consistent diagnosis, treatment, and research. This article explores the multifactorial roots…[...]

Read More